| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
APOE
|
apolipoprotein E
|
|
ARHGEF18
|
Rho/Rac guanine nucleotide exchange factor (GEF) 18
|
|
AZIN2
|
antizyme inhibitor 2
|
|
CAT
|
catalase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
ETV5
|
ets variant 5
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FOXP3
|
forkhead box P3
|
|
GADL1
|
glutamate decarboxylase-like 1
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GSS
|
glutathione synthetase
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNA2
|
interferon, alpha 2
|
|
IL10
|
interleukin 10
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IRF5
|
interferon regulatory factor 5
|
|
LUC7L3
|
LUC7-like 3 (S. cerevisiae)
|
|
MFRP
|
membrane frizzled-related protein
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTMR11
|
myotubularin related protein 11
|
|
MYO7A
|
myosin VIIA
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPVF
|
neuropeptide VF precursor
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
OAT
|
ornithine aminotransferase
|
|
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma
|
|
PLXNA2
|
plexin A2
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis)
|
|
RHO
|
rhodopsin
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
ROM1
|
retinal outer segment membrane protein 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TYR
|
tyrosinase
|
|
VEGFA
|
vascular endothelial growth factor A
|
